Status:
UNKNOWN
RCT for Evaluation of Insulin Administration,While Using the iPORT System
Lead Sponsor:
Assaf-Harofeh Medical Center
Conditions:
T1DM
Eligibility:
All Genders
1-18 years
Phase:
NA
Brief Summary
Type 1 diabetes is the most common chronic pediatric autoimmune disease, with a rising incidence rate in recent years around the world and in Israel Management includes multiple daily capillary glucos...
Detailed Description
Type 1 diabetes is the most common chronic pediatric autoimmune disease, with a rising incidence rate in recent years around the world and in Israel Management includes multiple daily capillary glucos...
Eligibility Criteria
Inclusion
- Diagnosis of type 1 diabetes within the last 4 weeks
- Need for insulin injections at least 1 times a day
- Age of 1-18 years.
- Agree to comply with all the terms of the study
- Has an iPhone, iOS 11 or higher OR Android
Exclusion
- Insulin pump therapy
Key Trial Info
Start Date :
October 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 1 2022
Estimated Enrollment :
35 Patients enrolled
Trial Details
Trial ID
NCT04421001
Start Date
October 1 2020
End Date
October 1 2022
Last Update
June 9 2020
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.